Aerosolized antibiotics for ventilator-associated pneumonia: Lessons from experimental studies

Anesthesiology

Volumn 117, Issue 6, 2012, Pages 1364-1380

  Rouby, Jean Jacques ^a   Bouhemad, Belaïd ^c   Monsel, Antoine ^b   Brisson, Hélène ^b   Arbelot, Charlotte ^b   Lu, Qin ^b  

^a Multidisciplinary Intensive Care Unit   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; GENTAMICIN; KANAMYCIN; POLYMYXIN B; TOBRAMYCIN; VANCOMYCIN;

AEROSOL; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERICIDAL ACTIVITY; CAPILLARY WALL; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; HUMAN; LUNG ALVEOLUS; LUNG INFECTION; LUNG PARENCHYMA; NEBULIZATION; NEBULIZER; NONHUMAN; PRIORITY JOURNAL; REVIEW; TURBULENT FLOW; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; NEBULIZERS AND VAPORIZERS; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL;

EID: 84870255889     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182755d7a     Document Type: Review

References (90)

1. Rouby JJ: Nosocomial infection in the critically ill: The lung as a target organ. Anesthesiology 1996; 84:757-9
2. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-44
3. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
4. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ: Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31:1312-7
5. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, Stobberingh EE: Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother 1997; 39:527-35
6. American Thoracic Society; Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
7. Fagon JY, Chastre J, Rouby JJ: Is bronchoalveolar lavage with quantitative cultures a useful tool for diagnosing ventilator-associated pneumonia? Crit Care 2007; 11:123
8. Chastre J: Infections due to Acinetobacter baumannii in the ICU. Semin Respir Crit Care Med 2003; 24:69-78
9. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP: Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use. JAMA 2003; 289:885-8
10. Rello J, Diaz E: Pneumonia in the intensive care unit. Crit Care Med 2003; 31:2544-51
11. Rouby JJ, Goldstein I, Lu Q: Inhaled Antibiotic Therapy. In Principles and Practice of Mechanical Ventilation (third edition). Edited by Tobin MJ. New York, McGraw-Hill Medical Publishing Division, 2006;1447-58
12. Luna CM, Sibila O, Agusti C, Torres A: Animal models of ventilator-associated pneumonia. Eur Respir J 2009; 33:182-8
13. Berendt RF, Knutsen GL, Powanda MC: Nonhuman primate model for the study of respiratory Klebsiella pneumoniae infection. Infect Immun 1978; 22:275-81
14. Berendt RF, Long GG, Abeles FB, Canonico PG, Elwell MR, Powanda MC: Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: Bacteriological and histological findings and metabolic alterations. Infect Immun 1977; 15:586-93
15. Berendt RF, Long GG, Walker JS: Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J Infect Dis 1975; 132:689-93
16. Esposito AL, Pennington JE: Effects of aging on antibacterial mechanisms in experimental pneumonia. Am Rev Respir Dis 1983; 128:662-7
17. Chiavolini D, Pozzi G, Ricci S: Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev 2008; 21:666-85
18. Mizgerd JP, Skerrett SJ: Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol 2008; 294:L387-98
19. Hutchens M, Luker GD: Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 2007; 9:2315-22
20. Bal HS, Ghoshal NG: Morphology of the terminal bronchiolar region of common laboratory mammals. Lab Anim 1988; 22:76-82
21. Johanson WG Jr, Holcomb JR, Coalson JJ: Experimental diffuse alveolar damage in baboons. Am Rev Respir Dis 1982; 126:142-51
22. Johanson WG Jr, Seidenfeld JJ, Gomez P, de los Santos R, Coalson JJ: Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137:259-64
23. Crouch TW, Higuchi JH, Coalson JJ, Johanson WG Jr: Pathogenesis and prevention of nosocomial pneumonia in a nonhuman primate model of acute respiratory failure. Am Rev Respir Dis 1984; 130:502-4
24. Johanson WG Jr, Seidenfeld JJ, de los Santos R, Coalson JJ, Gomez P: Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Am Rev Respir Dis 1988; 137:265-72
25. Marquette CH, Mensier E, Copin MC, Desmidt A, Freitag L, Witt C, Petyt L, Ramon P: Experimental models of tracheobronchial stenoses: A useful tool for evaluating airway stents. Ann Thorac Surg 1995; 60:651-6
26. Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB: Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999; 115:200-9
27. Rios Vieira SR, Goldstein I, Lenaour G, Marquette CH, Rouby JJ; Experimental ICU Study Group: Experimental ventilator-associated pneumonia: Distribution of lung infection and consequences for lung aeration. Braz J Infect Dis 2003; 7:216-23
28. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ: Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002; 166:1375-81
29. Martínez-Olondris P, Rigol M, Torres A: What lessons have been learnt from animal models of MRSA in the lung? Eur Respir J 2010; 35:198-201
30. Sartorius A, Lu Q, Vieira S, Tonnellier M, Lenaour G, Goldstein I, Rouby JJ: Mechanical ventilation and lung infection in the genesis of air-space enlargement. Crit Care 2007; 11:R14
31. Luna CM, Bruno DA, García-Morato J, Mann KC, Risso Patrón J, Sagardía J, Absi R, García Bottino M, Marchetti D, Famiglietti A, Baleztena M, Biancolini C: Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets. Chest 2009; 135:1564-71
32. Sibila O, Agustí C, Torres A, Baquero S, Gando S, Patrón JR, Morato JG, Goffredo DH, Bassi N, Luna CM: Experimental Pseudomonas aeruginosa pneumonia: Evaluation of the associated inflammatory response. Eur Respir J 2007; 30:1167-72
33. Rouby JJ, Martin De Lassale E, Poete P, Nicolas MH, Bodin L, Jarlier V, Le Charpentier Y, Grosset J, Viars P: Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146:1059-66
34. Martínez-Olondris P, Sibila O, Agustí C, Rigol M, Soy D, Esquinas C, Piñer R, Luque N, Guerrero L, Quera MÁ, Marco F, de la Bellacasa JP, Ramirez J, Torres A: An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets. Eur Respir J 2010; 36:901-6
35. Guerrero L, Martínez-Olondris P, Rigol M, Esperatti M, Esquinas C, Luque N, Piñer R, Torres A, Soy D: Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue. Clin Chem Lab Med 2010; 48:391-8
36. Martinez-Olondris P, Rigol M, Soy D, Guerrero L, Agusti C, Quera MA, Li Bassi G, Esperatti M, Luque N, Liapikou M, Filella X, Marco F, de la Bellacasa JP, Torres A: Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Crit Care Med 2012; 40:162-8
37. Goldstein I, Bughalo MT, Marquette CH, Lenaour G, Lu Q, Rouby JJ; Experimental ICU Study Group: Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001; 163:958-64
38. Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH, Rouby JJ: Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 2002; 165:171-5
39. Elman M, Goldstein I, Marquette CH, Wallet F, Lenaour G, Rouby JJ; Experimental ICU Study Group: Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002; 97:199-206
40. Tonnellier M, Ferrari F, Goldstein I, Sartorius A, Marquette CH, Rouby JJ: Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: Comparative effects of helium and nitrogen. Anesthesiology 2005; 102:995-1000
41. Ferrari F, Lu Q, Girardi C, Petitjean O, Marquette CH, Wallet F, Rouby JJ; Experimental ICU Study Group: Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa. Intensive Care Med 2009; 35:1792-800
42. Lu Q, Girardi C, Zhang M, Bouhemad B, Louchahi K, Petitjean O, Wallet F, Becquemin MH, Le Naour G, Marquette CH, Rouby JJ: Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 2010; 36:1147-55
43. Safdar N, Crnich CJ, Maki DG: The pathogenesis of ventilator-associated pneumonia: Its relevance to developing effective strategies for prevention. Respir Care 2005; 50:725-39; discussion 739-41
44. Bouhemad B, Liu ZH, Arbelot C, Zhang M, Ferarri F, Le-Guen M, Girard M, Lu Q, Rouby JJ: Ultrasound assessment of antibiotic-induced pulmonary reaeration in ventilator-associated pneumonia. Crit Care Med 2010; 38:84-92
45. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT: Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis 1990; 141:440-4
46. Dhand R, Guntur VP: How best to deliver aerosol medications to mechanically ventilated patients. Clin Chest Med 2008; 29:277-96, vi
47. Dhand R: Aerosol delivery during mechanical ventilation: From basic techniques to new devices. J Aerosol Med Pulm Drug Deliv 2008; 21:45-60
48. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC: Aerosol delivery and modern mechanical ventilation: In vitro/in vivo evaluation. Am J Respir Crit Care Med 2003; 168:1205-9
49. Brain JD, Valberg PA: Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979; 120:1325-73
50. Crogan SJ, Bishop MJ: Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 1989; 70:1008-10
51. O'Riordan TG, Palmer LB, Smaldone GC: Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 1994; 149:214-9
52. Dhand R, Tobin MJ: Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997; 156:3-10
53. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF: Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 1997; 10:905-9
54. Dubus JC, Vecellio L, De Monte M, Fink JB, Grimbert D, Montharu J, Valat C, Behan N, Diot P: Aerosol deposition in neonatal ventilation. Pediatr Res 2005; 58:10-4
55. Duarte AG, Fink JB, Dhand R: Inhalation therapy during mechanical ventilation. Respir Care Clin N Am 2001; 7:233-60, vi
56. Dhand R: Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002; 47:1406-16; discussion 1416-8
57. Dhand R: New frontiers in aerosol delivery during mechanical ventilation. Respir Care 2004; 49:666-77
58. Tronde A, Baran G, Eirefelt S, Lennernäs H, Bengtsson UH: Miniaturized nebulization catheters: A new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med 2002; 15:283-96
59. Dolovich MA: Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care 2000; 45:597-608
60. O'Doherty MJ, Thomas SH, Page CJ, Treacher DF, Nunan TO: Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis 1992; 146:383-8
61. Dhand R: Maximizing aerosol delivery during mechanical ventilation: Go with the flow and go slow. Intensive Care Med 2003; 29:1041-2
62. Hess DR, Dillman C, Kacmarek RM: In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: Pressure-control vs. volume control ventilation. Intensive Care Med 2003; 29:1145-50
63. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ: Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 1999; 159:63-8
64. Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ; Nebulized Antibiotics Study Group: Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 2011; 184:106-15
65. Ferron GA, Kerrebijn KF, Weber J: Properties of aerosols produced with three nebulizers. Am Rev Respir Dis 1976; 114:899-908
66. Habib DM, Garner SS, Brandeburg S: Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 1999; 19:143-9
67. Goode ML, Fink JB, Dhand R, Tobin MJ: Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001; 163:109-14
68. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA Jr: The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999; 115:184-9
69. Fàbregas N, Torres A, El-Ebiary M, Ramírez J, Hernández C, González J, de la Bellacasa JP, de Anta J, Rodriguez-Roisin R: Histopathologic and microbiologic aspects of ventilator-associated pneumonia. Anesthesiology 1996; 84:760-71
70. Matthay MA: Function of the alveolar epithelial barrier under pathologic conditions. Chest 1994; 105(3 Suppl):67S-74S
71. Wanner A, Salathé M, O'Riordan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996; 154(6 Pt 1):1868-902
72. Bauer TT, Torres A, Ferrer R, Heyer CM, Schultze-Werninghaus G, Rasche K: Biofilm formation in endotracheal tubes. Association between pneumonia and the persistence of pathogens. Monaldi Arch Chest Dis 2002; 57:84-7
73. Smith BR, LeFrock JL: Bronchial tree penetration of antibiotics. Chest 1983; 83:904-8
74. Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS: Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975; 293:471-5
75. Rouby JJ, Poète P, Martin de Lassale E, Nicolas MH, Bodin L, Jarlier V, Korinek AM, Viars P: Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study. Intensive Care Med 1994; 20:187-92
76. Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, Varela M, Tempone AK, O'Riordan T, Daroowalla F, Richman P: Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008-13
77. Pneumatikos IA, Dragoumanis CK, Bouros DE: Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology 2009; 110:673-80
78. Adair CG, Gorman SP, Byers LM, Jones DS, Feron B, Crowe M, Webb HC, McCarthy GJ, Milligan KR: Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med 2002; 28:426-31
79. Donlan RM, Costerton JW: Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93
80. Lorente L, Blot S, Rello J: New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2010; 182:870-6
81. Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ: Antibiotic tissue penetration and its relevance: Impact of tissue penetration on infection response. Antimicrob Agents Chemother 1991; 35:1953-9
82. Berendt RF, Long GG, Walker JS: Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother 1975; 8: 585-90
83. Berendt RF, Magruder RD, Frola FR: Treatment of Klebsiella pneumoniae respiratory tract infection of squirrel monkeys with aerosol administration of kanamycin. Am J Vet Res 1980; 41:1492-4
84. Berendt RF, Schneider MA, Young HW, Frola FR: Protection against Klebsiella pneumoniae respiratory tract infection of mice and squirrel monkeys given kanamycin by aerosol and injection. Am J Vet Res 1979; 40:1231-5
85. Makhoul IR, Merzbach D, Lichtig C, Berant M: Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: Comparison of aerosol and systemic administration. J Infect Dis 1993; 168:1296-9
86. Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Ardanuy C, Gudiol F: Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2002; 46:1946-52
87. Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, Tanabe Y, Gejyo F, Yamaguchi K: Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2009; 63:534-42
88. Barrowcliffe MP, Jones JG: Solute permeability of the alveolar capillary barrier. Thorax 1987; 42:1-10
89. Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006; 57:306-11
90. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME: Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005; 9:R53-9